Technology
The impact of technology on drug development activities has never been greater. Krystelis continues to invest in and apply technology solutions that enhance the value of our service offerings.

KrystelisClearAI
The power of AI to transform business activities is unquestionable. Krystelis has harnessed the potential of large language models (LLM) to develop and implement a tool that can be customised to create consistently and efficiently any type of plain language document aimed at a particular target reading level.
KrystelisDisclosureAI
Our AI-powered solution simplifies, standardises, and accelerates the generation of compliant trial registration records for ClinicalTrials.gov.
KrystelisClearPM
Robust project management underpins excellent service delivery. This includes timeline and resource management, cross-team communication and generation of appropriate performance indicators. Krystelis has deployed a web-based tool developed using a commercially available platform that manages these aspects through a simple interface. Access to this is provided to clients who can interact with our teams and monitor progress against deliverables and KQIs/KPIs in real time.
Document anonymisation
While Adobe Acrobat is suitable for redaction of documents, the more complex transformation approach to anonymisation benefits from the application of a purpose-built tool. The Krystelis team has for several years worked with one of the leading providers of anonymisation technology and we apply this solution to relevant dataset and document anonymisation projects.
Consulting services
Krystelis' services are based on our team's comprehensive understanding of current and upcoming regulatory requirements across all regions in which our clients operate. Several of our team members are recognised as global subject matter experts in their fields, for example, in clinical trial transparency and plain language writing. They contribute to the shaping of future regulations by producing thought papers, participating in industry forums, and contributing to proposed guidance from health authorities. We apply this knowledge not just to deliver our services, but also to help our clients build and adapt their internal processes in response to the continuously evolving regulatory landscape.
